ESR1 and breast carcinoma: Consistent with results from these preclinical studies, some epidemiologic studies have also indicated that effects of vitamin D may be strongest for breast cancers with poor prognostic characteristics and that lower serum 25OHD levels are found among women with ER- compared with ER+ tumors [19-21].